2020 | BioSenic

Bone Therapeutics announces expansion of its pipeline supported by funding from the Walloon Region

Read more about Bone Therapeutics announces expansion of its pipeline supported by funding from the Walloon Region

Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study

Read more about Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study

Bone Therapeutics announces Annual General Meeting results and confirms outlook for 2020

Read more about Bone Therapeutics announces Annual General Meeting results and confirms outlook for 2020

Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA

Read more about Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA

Bone Therapeutics: Information on the total number of voting rights and shares (May 2020)

Read more about Bone Therapeutics: Information on the total number of voting rights and shares (May 2020)

Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study

Read more about Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study

Bone Therapeutics to host Annual Ordinary General Meeting on 10 June 2020

Read more about Bone Therapeutics to host Annual Ordinary General Meeting on 10 June 2020

Bone Therapeutics raises additional EUR 4.0 million, with total of EUR 15 million committed, providing runway into Q2 2021

Read more about Bone Therapeutics raises additional EUR 4.0 million, with total of EUR 15 million committed, providing runway into Q2 2021

Bone Therapeutics Provides First Quarter 2020 Business Update

Read more about Bone Therapeutics Provides First Quarter 2020 Business Update

Bone Therapeutics secures EUR 11.0 million financing

Read more about Bone Therapeutics secures EUR 11.0 million financing

Subscribe to 2020